Therefore, as polymorphisms in ST3GAL6-AS1 are associated with altered expression of Siglec-9 and CD200R, this may provide further evidence for co-regulation of these proteins in pathological milieux, such as tumorigenesis in cancers including multiple myeloma. Here, ST3GAL6 is linked to cancer.